Effects of Structured Supervised Exercise Training or Motivational Counseling on Pregnant Women’s Physical Activity Level: FitMum – Randomized Controlled TrialRandomized Controlled Trial Published on 2022-07-202022-10-04 Journal: Journal of Medical Internet Research [Category] 임상, [키워드] 95% CI activity addition adjusted Adverse age Analysis association Attendance average baseline Changing commercial activity tracker complementary Compliance Controlled counseling COVID-19 Digital health doubly labeled water Effect effective evaluate the effect event EXE exercise fitness Garmin gold standard groups Health health outcome healthy hypothese IMPROVE inactive intensity Intervention intervention group investigated IQR Maternal Maternal Health maternity measure median motivation not affect not differ Offering participant performed physical physical activity physical activity questionnaire pregnancies Pregnancy pregnant pregnant women Primary outcome primary outcome analysis randomization Randomized Randomized controlled trial RCT recommendation Registered Safe Serious Adverse Event standard care tracker training was measured was performed women women's health would increase [DOI] 10.2196/37699 PMC 바로가기 [Article Type] Randomized Controlled Trial
Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysisArticle Published on 2022-07-092022-10-06 Journal: EClinicalMedicine [Category] 진단, [키워드] 95% CI adverse event AEs applied benefit cellular therapy China Chinese CNKI Cochrane Library control group Coronavirus disease-19 (COVID-19) COVID-19 Critical database Descriptive analysis development disease category dose doses Efficacy Efficacy and safety Egger Free heterogeneity in-hospital mortality in-hospital mortality rate Innovation less Mesenchymal stem cells Meta-analysis mortality rate MSC MSCs optics original Patient patients with COVID-19 Placebo plan Primary outcome Program reduce mortality Safe Safety Science searched Secondary outcomes significant difference small sample size standard care standard treatment stem cell stromal cell subgroup analysis Support systematic review technology the disease Tianjin Trade Treatment Trial two groups Valley was performed were used Wuhan [DOI] 10.1016/j.eclinm.2022.101545 PMC 바로가기 [Article Type] Article
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialClinical Trial Published on 2022-07-082022-10-05 Journal: The Lancet. Respiratory Medicine [Category] 임상, 진단, 치료법, [키워드] 1:1 addition adverse event Analysis assigned baseline Cohort Complete COVID-19 cumulative defined double-blind Europe extracorporeal membrane oxygenation finding Follow-up funding hazard ratio hospital discharge hospitalised hypothesised IMPROVE incidence infused intravenous Invasive mechanical ventilation investigators modified intention-to-treat monoclonal antibody combination Mortality neutralising NIH occurred operation Organ failure outcome participant Patient Phase 3 phase 3 trial Placebo placebo group placebo-controlled trial Primary outcome randomised Randomly receive receiving Registered Remdesivir renal replacement therapy Result Safe seronegative Singapore speed standard care study drug Study participants Support sustained Symptom the placebo group therapy Treatment Uganda USA were excluded with COVID-19 [DOI] 10.1016/S2213-2600(22)00215-6 [Article Type] Clinical Trial
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies분무형 HepArin이 침습적 인공호흡이 필요한 COVID-19 환자의 사망률과 발관까지의 시간을 줄일 수 있습니까?Article Published on 2022-07-012022-09-11 Journal: British Journal of Clinical Pharmacology [Category] COVID19(2023년), SARS, 임상, [키워드] Activation alveolar fibrin Analysis Anti-inflammatory ARDS blinded Can clinical study clinical trial Coagulation controlled clinical trials country COVID-19 COVID-19 pneumonia dataset days alive defined Effect endpoints Evidence extubation FIBRIN FIVE heparin hypoxaemic respiratory failure Infection Inhaled International invasive ventilation investigator-initiated Laboratory limit lung Lung injury mammalian cells meta-trial Microvascular thrombosis nebulised heparin open label pandemic patient data patients with COVID-19 Placebo placebo-controlled Pneumonia Prevent Primary outcome progression randomised randomised controlled randomised study RCT receive Respiratory failure resulting SARS SARS-CoV-2 SARS-CoV-2 virus standard care Statistical analysis plan the SARS-CoV-2 virus therapy thrombosis unfractionated heparin ventilator-free day Ventilator-free days with COVID-19 [DOI] 10.1111/bcp.15253 PMC 바로가기 [Article Type] Article
Safety and Efficacy of Siddha Medicine preparation in the management of COVID-19: A Prospective Randomised Open Label StudyResearch article Published on 2022-07-012022-10-05 Journal: Journal of Ayurveda and Integrative Medicine [Category] 임상, [키워드] 1:1 adverse events age average AYUSH baseline breathing ambient air CAM therapy clinical marker clinical symptom clinical trial complementary conducted control group COVID 19 patients COVID-19 COVID-19 patients Efficacy and safety group hospitalisation Hospitalized interquartile range Intervention intervention group lAbel management Medicine Mild Moderate COVID-19 objective open label oxygen saturation pandemic participated Patient patients hospitalized primary end point Prospective randomised Randomized receiving reduction in reported Result Safety SARS-COV-2 infection Seven Siddha spread of COVID-19 standard care statistically Symptom therapy Traditional medicine Trial two group [DOI] 10.1016/j.jaim.2022.100597 [Article Type] Research article
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trialClinical Trial Published on 2022-06-282022-10-05 Journal: Stem Cell Research & Therapy [Category] 임상, [키워드] acute respiratory distress syndrome addition adverse effect approach ARDS ARDS patient ARDS patients Cell change clinical clinical trial control group correlated COVID-19 pandemic COVID-19 patient CRP level CT scan Cytokine storm demonstrated disease distress Features follow-up period functions IFN-g IL-10 IL-17 IL-1B IL-6 Inflammatory cytokines injection Intervention intervention group intravenous intravenous infusion Mesenchymal stromal cells Mild-to-moderate MSC MSCs Open-label Patient Registered registry required respiratory Safe Safety Sample size serum CRP serum cytokine serum cytokine level significant decrease significant increase single-center SPO standard care stromal cell study period syndrome therapy TNF-α UC-MSC UC-MSCs umbilical were assessed [DOI] 10.1186/s13287-022-02920-1 PMC 바로가기 [Article Type] Clinical Trial
The Effects of Theory-Based Educational Intervention and WhatsApp Follow-up on Papanicolaou Smear Uptake Among Postnatal Women in Malaysia: Randomized Controlled TrialRandomized Controlled Trial Published on 2022-06-272022-10-05 Journal: JMIR mHealth and uHealth [Category] 임상, [키워드] analyzed assigned Attitude baseline both group Cancer changed clinical clinics Cluster conducted control group control groups Controlled COVID-19 pandemic demonstrated determine Effect effective Effectiveness Factors first stage Follow-up form Google Health health knowledge high uptake IBM Intervention intervention group intervention study investigated knowledge knowledge score Malaysia mortality rate multifactorial Negeri Sembilan Neoplasms p value Papanicolaou test participant Patient Population Practice previous study primary endpoint proportion Psychological psychological theory questionnaire Randomized controlled trial Randomly reduce registry researcher secondary endpoint Self-efficacy shown Significant single-blind smear social media SPSS standard care statistically significant tested theory uptake uterine uterine cervical neoplasms. was used WhatsApp withdrawn women [DOI] 10.2196/32089 PMC 바로가기 [Article Type] Randomized Controlled Trial
Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trialRandomized Controlled Trial Published on 2022-06-022022-10-04 Journal: Scientific Reports [Category] 바이오마커, 임상, 치료법, [키워드] Admission aggravate anti-inflammatory treatment applied Arm benefit clinical benefit Colchicine colchicine group colchicine treatment components CPAP Cytokine storm syndrome death develop dose Efficacy Endpoint EudraCT hospitalized patient hyperinflammation ICU admission in both groups intensive care Invasive mechanical ventilation investigator-initiated trial mechanical ventilation moderate Most patient Non-invasive observer-blinded occurred outcome outcome measure Patient patients with COVID-19 Pneumonia Primary outcome pulmonary disease Randomized randomized clinical trial Randomly receive Severe COVID-19 pneumonia standard care steroid study population Trial with COVID-19 [DOI] 10.1038/s41598-022-13424-6 PMC 바로가기 [Article Type] Randomized Controlled Trial
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients순환하는 칼프로텍틴의 역학은 중등도의 COVID-19 환자의 결과를 정확하게 예측합니다Article Published on 2022-06-012022-09-11 Journal: EBioMedicine [Category] MERS, 바이오마커, 진단, [키워드] Admission age alarmin Algorithm baseline Biomarker body mass body mass index calprotectin circulating Cohort collected Comorbidities Comorbidity Course COVID-19 COVID19 death defined Diagnosis disease severity Dynamics foundation France Gustave Roussy high risk Hospitalization Hospitalized identify independent intensive care intensive care unit joint latent class measure mixture model moderate Moderate COVID-19 MONITOR outcome Patient patients patients with moderate performed Peripheral blood plasma predict Predictive Predictive value Probability Research risk S100A8 S100A8/A9 S100A9 Serial measurement. serum severe COVID-19 Sex standard care Support Thermofisher trajectory transfer [DOI] 10.1016/j.ebiom.2022.104077 PMC 바로가기 [Article Type] Article
Effect of ArtemiC in patients with COVID-19: A Phase II prospective studyClinical Trial Published on 2022-06-012022-10-04 Journal: Journal of Cellular and Molecular Medicine [Category] COVID19(2023년), SARS, 임상, [키워드] adverse event Anti-inflammatory anti-SARS-CoV-2 ArtemiC Artemisinin blood test COVID-19 COVID-19 patient COVID-19 patients curcumin. Cytokine storm Day Decline Deterioration double-blinded Effect effective Efficacy and safety evaluated Fever hospital discharge Hospitalized Intensive lineages new SARS-CoV-2 NEWS2 oxygen supplementation Patient patients with COVID-19 PCR pharmacological phase Physical examination Placebo placebo-controlled Prospective Study Randomized receive reported SARS-CoV-2 standard care symptomatic those with comorbidities unmet need vaccination efficacy vital sign Vitamin Vitamin C was performed [DOI] 10.1111/jcmm.17337 PMC 바로가기 [Article Type] Clinical Trial